We are excited to announce that on the 22nd March, Renaissance Pharma Ltd was purchased by Essential Pharma to facilitate and stimulate an expansion into rare disease medicine. Renaissance, and our lead asset – Hu1418 - will now reap the benefit of having access to the immediate financial and operational backing that it requires. Under the Essential banner, every effort will be made to ensure this antibody is made available for those receiving the very difficult diagnosis of high-risk neuroblastoma; step by step we will knock over operational and clinical milestones to ensure that product availability occurs as expeditiously as possible. This remains our goal. Read the full announcement here: https://lnkd.in/ee6rJrYr #neuroblastoma #childhoodcancer #oncology #raredisease
Renaissance Pharma Ltd
Biotechnology Research
Manchester, England 437 followers
Enhancing and enriching therapeutic options in paediatric medicine
About us
We are a global, clinical stage pharmaceutical company with a mission to develop and commercialise clinically meaningful, novel therapeutics that will bring life-enhancing benefits to children across the world. Our first development program focuses on Hu14.18, a humanised anti-GD2 monoclonal antibody, licensed from St. Jude Children’s Research Hospital for the treatment of newly diagnosed high-risk neuroblastoma. A novel key Phase II trial incorporated the addition of Hu14.18 antibody to standard induction chemotherapy and demonstrated outstanding outcomes in patients with newly diagnosed high-risk neuroblastoma, with a 3-year event-free (EFS) and overall survival (OS) of 73.7% and 86.0% respectively. Renaissance Pharma Ltd is led by an Executive Team with extensive experience in the development, approval and commercialisation of oncology and rare disease products. We invite industry manufacturers, formulators, researchers and investors to collaborate with us. Together we can build new partnerships to improve patients' lives. To discuss partnership opportunities, please contact info@renaissancepharma.co.uk
- Website
-
www.renaissancepharma.co.uk
External link for Renaissance Pharma Ltd
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Manchester, England
- Type
- Privately Held
- Founded
- 2023
Locations
-
Primary
Get directions
Manchester, England, GB
Employees at Renaissance Pharma Ltd
-
Jonathan Morgan
-
Sam Collaudin
PhD - Business strategy Biotech - Solidarity finance, Cigales, Social & Solidarity Economy, Cooperation
-
Lee Andrus
Currently a machine operator for Renaissance Pharmaceuticals. Extensive background in the sports betting and thoroughbred racing industries as well…